Table 2.
Findings of selected studies in sub-Saharan Africa based on human immunodeficiency virus status
| Study | Countries | Study period | Cases, n | High-risk HPV (%) | Multiple-HPV prevalence (%) | Order of 6 most prevalent high-risk HPV types | |
|---|---|---|---|---|---|---|---|
| Cross-sectional studies (HIV+/HIV-) | |||||||
| Mpunga et al. [32]1 | Rwanda | 2012-2018 | 598 | 574 (96.0) | 28 (4.7) | 16, 18, 45, 33, 35, 52 | |
| Mudini et al. [20]1 | Zimbabwe | 2014-2015 | 107 | 101 (94.4) | 55 (51.4) | 16, 18, 56, 33, 45, 35 | |
| Banura et al. [35] | Uganda | 2002-2004 | 950 | 707 (74.4) | 377 (39.7) | 52,16, 18, 51, 33, 56 | |
| Diop-Ndiaye et al. [29]2 | Senegal | 2010 | 436 | 316 (72.5) | NA | 52, 16, 68, 35, 51, 33 | |
| Marembo et al. [33] | Zimbabwe | 2015 | 136 | 70 (51.5) | 27 (19.9) | 18, 52, 16, 58, 51, 31 | |
| Obiri-Yeboah et al. [37] | Ghana | 2017 | 329 | 156 (47.4) | 113 (34.3) | 35, 58, 52, 18, 56, 16/56 | |
| Maranga et al. [34] | Kenya | 2008-2009 | 224 | 105 (46.9) | 37 (16.5) | 56, 52, 58, 16, 35, 33 | |
| Akarolo-Anthony et al. [21] | Nigeria | 2012 | 257 | 64 (24.9) | 23 (8.9) | 82, 35, 56, 58, 45, 59 | |
| Ndizeye et al. [36] | Burundi | 2013/2016 | 600 | 142 (23.7) | 37 (6.2) | 16, 18, 58, 52, 51, 31 | |
| Ezechi et al. [38] | Nigeria | 2014 | 515 | 101 (19.6) | 28 (5.4) | 16, 35, 58, 31, 18, 52 | |
| McDonald et al. [41] | SA | 1999-2006 | 9,691 | 1,848 (19.1) | 550 (5.7) | 35, 16, 58, 45, 18, 52 | |
| Total [20, 21, 29, 32-38, 41] | Africa | 1999-2018 | 13,843 | 4,184 (30.2) | 1,275 (9.5) | 16, 18, 35, 52, 45, 58 | |
| Cohort studies (HIV+ only) | |||||||
| Yakub et al. [18] | Nigeria | 2016-2017 | 220 | 83 (37.7) | 25 (11.4) | 35, 16, 45, 33, 18, 56 | |
| Menon et al. [19]3 | Kenya | 2009-2015 | 74 | 52 (70.2) | 48 (64.9) | 16, 53, 52, 56, 18/35/58 | |
| Kelly et al. [39] | Burkina Faso | 2011-2012 | 621 | 491 (79.1) | 271 (43.6) | 52, 16, 35, 51, 18, 31 | |
| Kelly et al. [39] | SA | 2011-2012 | 594 | 351 (59.1) | 147 (24.7) | 52, 51, 35, 16, 31, 39 | |
| Dols et al. [30] | Tanzania/SA | 2008-2010 | 194 | 109 (56.2) | NA | 52, 16, 51, 35, 58, 18 | |
| Guthrie et al. [40] | Kenya | 2007-2009 | 283 | 176 (62.2) | 122 (43.1) | 52, 18, 16, 51, 35, 68 | |
| Denny et al. [31] | SA | 2000-2003 | 400 | 301 (75.3) | NA | 16, 52, 53, 35, 18, 58 | |
| Total [18, 19, 30, 31, 39, 40] | Africa | 2000-2017 | 2,386 | 1,563 (65.5) | 613 (34.2) | 52, 16, 35, 18, 51, 31 | |
HPV, human papillomavirus; HIV+, human immunodeficiency virus seropositive; HIV-, human immunodeficiency virus seronegative; NA, not available; SA, South Africa; FSW, female sex workers.
1
Cancer,
2
FSW.
3
FSW with abnormal cytology.